A Study of CRLX101(NLG207) in Combination With Weekly Paclitaxel in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Clinical trial NCT02389985 · TERMINATED
Trial details
- NCT number
- NCT02389985
- Sponsor
- NewLink Genetics Corporation
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2018-06-04
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.